These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 5371198

  • 41. The preparation and pharmacology of some 11-beta-hydroxy-4-methylestratrienes.
    Chinn LJ.
    J Med Chem; 1968 Jul; 11(4):902-4. PubMed ID: 5671272
    [No Abstract] [Full Text] [Related]

  • 42. Heterocyclic steroids. IV. Total synthesis of some 6-aza-estrogens.
    Speckamp WN, de Koning H, Pandit UK, Huisman HO.
    Tetrahedron; 1965 Sep; 21(9):2517-27. PubMed ID: 5879296
    [No Abstract] [Full Text] [Related]

  • 43. Effects of estrogen therapy on whole body proteins.
    Mauras N.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):431. PubMed ID: 8550791
    [No Abstract] [Full Text] [Related]

  • 44. Density as an index of the effects of estrogens on bone.
    CALHOUN DW, EDGREN RA.
    Endocrinology; 1956 Dec; 59(6):631-6. PubMed ID: 13375587
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents.
    Nutting EF, Calhoun DW.
    Endocrinology; 1969 Feb; 84(2):441-2. PubMed ID: 5764313
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Future therapeutic targets in osteoporosis.
    Deal C.
    Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
    [Abstract] [Full Text] [Related]

  • 51. The influence of steroids on the skeleton.
    Overbeek GA, van Vliet NP, van der Vies J, de Visser J, Crombag FJ, Assendorp R.
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):420. PubMed ID: 5371198
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents.
    Nutting EF, Calhoun DW.
    Endocrinology; 1969 Feb; 84(2):441-2. PubMed ID: 5764313
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
    Sharan K, Mishra JS, Swarnkar G, Siddiqui JA, Khan K, Kumari R, Rawat P, Maurya R, Sanyal S, Chattopadhyay N.
    J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
    [Abstract] [Full Text] [Related]

  • 56. The influence of steroids on the skeleton.
    Overbeek GA, van Vliet NP, van der Vies J, de Visser J, Crombag FJ, Assendorp R.
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):420. PubMed ID: 5371198
    [No Abstract] [Full Text] [Related]

  • 57. Future therapeutic targets in osteoporosis.
    Deal C.
    Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Estrogen, calcium metabolism and the skeleton.
    Lindsay R, Cosman F.
    Ann N Y Acad Sci; 1991 Jul; 622():307-14. PubMed ID: 2064191
    [No Abstract] [Full Text] [Related]

  • 60. Nitrogen-retaining steroids and their application in disease.
    Querido A, Kassenaar AA.
    Adv Metab Disord; 1965 Jul; 2():79-113. PubMed ID: 4924372
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.